Home

Lincoln Pharmaceuticals Ltd PE Ratio

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

PE

16.4

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Lincoln Pharmaceuticals Ltd is 16.4 as of 15 Jan 13:57 PM .
  • The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 5.2 on March 2020 to 12.6 on March 2024 . This represents a CAGR of 19.36% over 5 years.
  • The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 776.1 as of 15 Jan 13:51 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

No data available

Company Fundamentals for Lincoln Pharmaceuticals Ltd

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

Share Price

₹ 776.1

-13.85 (-1.75%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Lincoln Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Lincoln Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025789.95
13 Jan 2025768
10 Jan 2025805.75
09 Jan 2025809.25
08 Jan 2025821.95
07 Jan 2025835.55
06 Jan 2025804.95
03 Jan 2025856.9
02 Jan 2025845.75
01 Jan 2025854.55

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Lincoln Pharmaceuticals Ltd

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Lincoln Pharmaceuticals Ltd1582
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Lincoln Pharmaceuticals Ltd Explained

``

1582

Market cap

96

Earnings

16.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Lincoln Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Lincoln Pharmaceuticals Ltd

No data available

* All values are in %

About Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
  • All the assets and business of the erstwhile partnership were transferred to the Company.
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

Lincoln Pharmaceuticals Ltd News Hub

Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 a

Read more

2024-08-09 00:00:00

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

2024-09-03 00:00:00

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November

Read more

2024-11-07 00:00:00

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

2024-09-03 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lincoln Pharmaceuticals Ltd

What is the current PE Ratio of Lincoln Pharmaceuticals Ltd?

The Current PE Ratio of Lincoln Pharmaceuticals Ltd is 16.37 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Lincoln Pharmaceuticals Ltd last year?

The PE Ratio of Lincoln Pharmaceuticals Ltd was 9.3 last year, now the PE ratio is 16.37, showing a year-on-year growth of 76.0%.

What does the PE Ratio of Lincoln Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Lincoln Pharmaceuticals Ltd is 16.37. This ratio indicates that investors are willing to pay 16.37 times the earnings per share for each share of Lincoln Pharmaceuticals Ltd.

What is the PE Ratio Growth of Lincoln Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lincoln Pharmaceuticals Ltd grew by 76.0% whereas, the EPS ratio grew by 11.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions